Remove Books Remove DNA Remove Immune Response
article thumbnail

Is Recent Gene Therapy Setback for Duchenne Muscular Dystrophy (DMD) Déjà vu All Over Again?

PLOS: DNA Science

In the final chapter of my 2012 book The Forever Fix: Gene Therapy and the Boy Who Saved It , I predicted that the technology would soon expand well beyond the rare disease world. Can they deliver healing genes without triggering an overactive immune response? million DNA bases. I was overoptimistic. Muscles stop working.

article thumbnail

The Forgotten Pandemic

Codon

The Most Deadly Infectious Disease “Each successive episode of bleeding left him weaker than before,” wrote Mary Doria Russell of Doc Holliday, the gunslinging gambler, in her eponymous book, Doc. Published in 1971, the book contains unsparing descriptions of Holliday’s deteriorating medical condition. tuberculosis.

article thumbnail

CRISPR Tackles Diverse Single-Gene Conditions

PLOS: DNA Science

.” CRISPRs are short DNA sequences, peppered with repeats, that latch onto DNA-cutting enzymes, commandeering and directing them to snip certain parts of a chromosome. The microbes deploy them to dismantle the genetic material of infecting viruses, a little like an immune response.

article thumbnail

Codon Digest: Seeing Colors After Gene Therapy

Codon

They’ve just finished sequencing the patient’s genome, but they don’t have “DNA sorting” software. And that’s how I learned that there are published books that contain entire chromosome sequences. A real book that contains the full sequence of human chromosome 21.

article thumbnail

Codon Digest: Seeing Colors After Gene Therapy

Codon

They’ve just finished sequencing the patient’s genome, but they don’t have “DNA sorting” software. And that’s how I learned that there are published books that contain entire chromosome sequences. A real book that contains the full sequence of human chromosome 21.

article thumbnail

INOVIO Announces Pricing of Public Offering of Common Stock – Jan 21, 2021

The Pharma Data

Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, including COVID-19, cancer and HPV-associated diseases, today announced the pricing of an underwritten public offering of 17,700,000 shares of its common stock at a public offering price of $8.50

DNA 40
article thumbnail

Codon Digest: Vaccine Printer Go Brrrrr!

Codon

Yeast die for two reasons: Either their nucleolus (where the DNA is kept) degrades and dies, or their mitochondria whimpers out and they stop making energy. The vaccine printer can make lots of different types of vaccines, including protein, DNA, and mRNA ones, but I’m sure this is all quite expensive right now. From Zhang et al.

Vaccine 52